Skip to main content
. 2011 Nov 24;82(5):559–566. doi: 10.3109/17453674.2011.625533

Table 3.

Whole-blood cobalt and chromium concentrations, values (µg/L) are median (range)

Preoperative 6 months 12 months 24 months
R C R C R C R C
Unilateral implants
(n=33) (n=29) (n=33) (n=29) (n=33) (n=28) (n=16) (n=17)
Co 0.1 (0.1–0.8) 0.1 (0.1–0.6) 1.3 (0.1–23) a 0.85 (0.1–4.0) a 1.25 (0.6–8.3) 1.0 (0.1–4.2) 1.2 (0.5–22) 0.9 (0.1–2.7)
Cr 0.1 (0.1–1.4) 0.1 (0.1–0.1) 1.1 (0.1–15) a 0.1 (0.1–2.9) a 1.0 (0.1–6.1) a 0.5 (0.1–2.0) a 1.2 (0.1–10) a 0.5 (0.1–2.1) a
Bilateral implants
(n=5) (n=4) (n=5) (n=4) (n=5) (n=4) (n=3) (n=4)
Co 0.3 (0.1–1.1) 0.1 (0.1–1.8) 1.7 (1–7.9) 0.85 (0.5–2.2) 1.9 (0.9–11) 1.15 (0.8–1.3) 2.0 (0.7–6.0) 1.4 (0.7–1.8)
Cr 0.1 (0.1–0.9) 0.1 (0.1–0.8) 1.7 (0.1–3.8) 0.25 (0.1–1.5) 2.2 (0.1–4.9) 0.5 (0.1–0.8) 1.5 (0.1–2.3) 0.75 (0.6–0.8)

a Significant difference between resurfacing (R) and conventional (C) hip arthroplasty (p ≤ 0.05).